Abstract |
Oxymatrine (OMTR) is an anti- hepatitis drug used in China. Its mechanism of action is unknown. Recently, we found that OMTR inhibits hepatitis B virus (HBV) via down-regulating the expression of heat-stress cognate 70 (Hsc70), a host protein required for HBV DNA replication. Goal of this study was to assess the effect of OMTR on clinical HBV drug-resistance. OMTR monotherapy (oral, 12 months) reduced blood HBV DNA by 96% and HBeAg by 70% in the chronic hepatitis B (CHB) patients resistant to lamivudine (n = 17), equal to its efficacy in the naïve CHB cohort (n = 20). Liver biopsy study showed that OMTR treatment caused a decrease of Hcs70 mRNA in liver cells, parallel with a reduction of intracellular HBV DNA. Combination of lamivudine with OMTR (n = 15) (oral, 12 months) showed an enhanced anti-HBV effect as compared to lamivudine monotherapy (n = 25). The incidence of drug resistance against lamivudine in the combination group was significantly lower than that in the lamivudine group (1/15 vs 7/25; p<0.01). The results were further confirmed in vitro. Treatment of HBV(+) HepH2215 cells with sub-optimal dose of OMTR for 8 months suppressed HBV replication without inducing drug resistance, whereas lamivudine monotherapy caused drug-resistant mutation in 3 months. Combination of OMTR with lamivudine prevented HBV from developing drug resistance.
|
Authors | Yu-Ping Wang, Wei Zhao, Rong Xue, Zhen-Xian Zhou, Fei Liu, Yan-Xing Han, Gang Ren, Zong-Gen Peng, Shan Cen, Hong-Shan Chen, Yu-Huan Li, Jian-Dong Jiang |
Journal | Antiviral research
(Antiviral Res)
Vol. 89
Issue 3
Pg. 227-31
(Mar 2011)
ISSN: 1872-9096 [Electronic] Netherlands |
PMID | 21277330
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier B.V. All rights reserved. |
Chemical References |
- Alkaloids
- Antiviral Agents
- DNA, Viral
- HSC70 Heat-Shock Proteins
- HSPA8 protein, human
- Hepatitis B e Antigens
- Quinolizines
- Lamivudine
- oxymatrine
|
Topics |
- Administration, Oral
- Adult
- Alkaloids
(administration & dosage, pharmacology)
- Antiviral Agents
(administration & dosage, pharmacology)
- Biopsy
- China
- DNA, Viral
(blood)
- Down-Regulation
- Drug Resistance
- Drug Therapy, Combination
- Female
- Gene Expression Profiling
- HSC70 Heat-Shock Proteins
(biosynthesis)
- Hepatitis B e Antigens
(blood)
- Hepatitis B virus
(drug effects)
- Hepatitis B, Chronic
(drug therapy)
- Humans
- Lamivudine
(administration & dosage)
- Liver
(pathology)
- Male
- Middle Aged
- Quinolizines
(administration & dosage, pharmacology)
- Treatment Outcome
- Viral Load
|